Replies to post #1250 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Orencia is plenty big enough for a US FoB to be a consequential product for MNTA (see #msg-56471065), but it is not so big that it is likely to attract a lot of FoB competition. Thus, if MNTA believes that the patents are weak, Orencia could be an ideal FoB candidate.